Literature DB >> 15242873

Suspended cells from trabecular bone by collagenase digestion become virtually identical to mesenchymal stem cells obtained from marrow aspirates.

Yusuke Sakaguchi1, Ichiro Sekiya, Kazuyoshi Yagishita, Shizuko Ichinose, Kenichi Shinomiya, Takeshi Muneta.   

Abstract

Several reports describe that the explant culture of the trabecular bone after collagenase treatment produces mesenchymal stem cells (MSCs). However, the suspended cells had not been intensively examined concerning MSCs. We hypothesized that the cells would acquire the properties of MSCs during their expansion and therefore compared them with marrow aspirate-derived MSCs. Human trabecular bones were washed, digested, filtered, and expanded clonally for 14 days. Their proliferation ability (n = 9) and differentiation potentials for chondrocyte, adipocyte, and osteoblast (n = 6) were similar with those of marrow aspirate-derived MSCs. Epitope and mRNA analysis revealed some differences in both types of cells, which disappeared with expansion and subcultivation. A mixed population of collagenase-released (CR) cells had similar differentiation potentials with CR clone, CD31(+) fraction, and osteoblastic cells. For quantitative study, trabecular bone and bone marrow were harvested by single aspiration using a biopsy needle (n = 16). Although the total nucleated cell number harvested was similar, the colony-forming efficiency of CR cells was approximately 100-fold higher than that of BM cells and more than 1 million CR cells could be obtained in 14 days from all donors. Enzymatically released cells from trabecular bone became virtually identical to marrow aspirate-derived MSCs, demonstrating that a trabecular bone fragment can be an alternative source of MSCs.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15242873     DOI: 10.1182/blood-2003-12-4452

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  75 in total

Review 1.  Moving from the laboratory bench to patients' bedside: considerations for effective therapy with stem cells.

Authors:  Lauren S Sherman; Jessian Munoz; Shyam A Patel; Meneka A Dave; Ilani Paige; Pranela Rameshwar
Journal:  Clin Transl Sci       Date:  2011-10       Impact factor: 4.689

2.  Fibroblast growth factor-2 stimulates the proliferation of mesenchyme-derived progenitor cells from aging mouse and human bone.

Authors:  Guomin Ou; Lyndon Charles; Seth Matton; Craig Rodner; Marja Hurley; Liisa Kuhn; Gloria Gronowicz
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2010-07-19       Impact factor: 6.053

3.  Mechanical and Vascular Cues Synergistically Enhance Osteogenesis in Human Mesenchymal Stem Cells.

Authors:  Andrew J Steward; Jacqueline H Cole; Frances S Ligler; Elizabeth G Loboa
Journal:  Tissue Eng Part A       Date:  2016-07-29       Impact factor: 3.845

4.  Influence on mitochondria and cytotoxicity of different antibiotics administered in high concentrations on primary human osteoblasts and cell lines.

Authors:  N Duewelhenke; O Krut; P Eysel
Journal:  Antimicrob Agents Chemother       Date:  2006-11-06       Impact factor: 5.191

5.  Antigen-presenting property of mesenchymal stem cells occurs during a narrow window at low levels of interferon-gamma.

Authors:  Jennifer L Chan; Katherine C Tang; Anoop P Patel; Larissa M Bonilla; Nicola Pierobon; Nicholas M Ponzio; Pranela Rameshwar
Journal:  Blood       Date:  2006-02-21       Impact factor: 22.113

6.  Amniotic fluid stem cells produce robust mineral deposits on biodegradable scaffolds.

Authors:  Alexandra Peister; Eric R Deutsch; Yash Kolambkar; Dietmar W Hutmacher; Robert E Guldberg
Journal:  Tissue Eng Part A       Date:  2009-10       Impact factor: 3.845

7.  Biological properties of mesenchymal Stem Cells from different sources.

Authors:  Alessio Giai Via; Antonio Frizziero; Francesco Oliva
Journal:  Muscles Ligaments Tendons J       Date:  2012-10-16

Review 8.  Concise review: cell-based strategies in bone tissue engineering and regenerative medicine.

Authors:  Jinling Ma; Sanne K Both; Fang Yang; Fu-Zhai Cui; Juli Pan; Gert J Meijer; John A Jansen; Jeroen J J P van den Beucken
Journal:  Stem Cells Transl Med       Date:  2013-12-03       Impact factor: 6.940

9.  Supercharging allografts with mesenchymal stem cells in the operating room during hip revision.

Authors:  Yasuhiro Homma; Kazuo Kaneko; Philippe Hernigou
Journal:  Int Orthop       Date:  2013-12-10       Impact factor: 3.075

10.  Variation in primary and culture-expanded cells derived from connective tissue progenitors in human bone marrow space, bone trabecular surface and adipose tissue.

Authors:  Maha A Qadan; Nicolas S Piuzzi; Cynthia Boehm; Wesley Bova; Malcolm Moos; Ronald J Midura; Vincent C Hascall; Christopher Malcuit; George F Muschler
Journal:  Cytotherapy       Date:  2018-02-01       Impact factor: 5.414

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.